Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

MRI for Assessment of Hypoxia-Induced Prostate Cancer Aggressiveness

NCT01464216 is registered in ClinicalTrials.gov with Oslo University Hospital as lead sponsor.

NCT NCT01464216
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01464216 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
MRI for Assessment of Hypoxia-Induced Prostate Cancer Aggressiveness
Lead sponsor
Oslo University Hospital
Phase
Observational
Overall status
Active, not recruiting
Start date
October 31, 2011
Completion date
December 31, 2030
Enrollment
120 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

genital neoplasms, male, prostatic diseases, prostatic neoplasms